(AZBJ) AllianzIM U.S. Large Cap - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US00888H8025

FLEX Options, S&P 500, Defined Outcome

Description: AZBJ AllianzIM U.S. Large Cap

The AllianzIM U.S. Large Cap Buffer20 Jan ETF (AZBJ) is an exchange-traded fund that employs a defined outcome strategy, aiming to provide a buffer against losses in the S&P 500 Price Index while maintaining upside potential. Under normal market conditions, the fund invests at least 80% of its net assets in FLEX Options that reference the S&P 500, effectively gaining exposure to U.S. large-cap equities.

The funds investment strategy is centered around FLEX Options, which are customized options contracts that can be tailored to meet specific investment objectives. By investing in these options, AZBJ seeks to benefit from the performance of the S&P 500 while mitigating potential losses. The funds non-diversified nature means that it may be more susceptible to volatility and market fluctuations.

Analyzing the funds recent performance, we can observe that it has been trading above its 20-day and 50-day simple moving averages (SMA20 and SMA50), indicating a positive short-term trend. The Average True Range (ATR) is relatively low at 1.26%, suggesting that the funds price movements have been relatively stable. Given the current technical setup, with the last price at $33.40 and the SMA20 at $32.82, we can anticipate a potential continuation of the upward trend, with a possible target near the 52-week high of $34.29.

Considering the fundamental data, the funds Assets Under Management (AUM) stand at $463.18 million, indicating a moderate level of investor interest. As the fund is designed to provide a buffer against losses, its appeal may grow in times of market uncertainty or increased volatility. With the S&P 500 being a widely followed benchmark, any significant movements in the index are likely to impact the funds performance. Based on the current technical and fundamental analysis, we forecast that AZBJ may continue to trade within a narrow range, potentially consolidating around the $33.00 level before making its next move. A break above the 52-week high could signal further upside potential, while a decline below the SMA50 may indicate a shift in the funds trend.

Additional Sources for AZBJ ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

AZBJ ETF Overview

Market Cap in USD 483m
Category Defined Outcome
TER 0.74%
IPO / Inception 2020-12-31

AZBJ ETF Ratings

Growth Rating 67.7
Fundamental -
Dividend Rating 0.0
Rel. Strength -5.44
Analysts -
Fair Price Momentum 33.32 USD
Fair Price DCF -

AZBJ Dividends

Currently no dividends paid

AZBJ Growth Ratios

Growth Correlation 3m 92.9%
Growth Correlation 12m 68.5%
Growth Correlation 5y 89.1%
CAGR 5y 7.67%
CAGR/Max DD 5y 0.79
Sharpe Ratio 12m 0.86
Alpha 0.12
Beta 0.355
Volatility 5.19%
Current Volume 20.4k
Average Volume 20d 21.3k
What is the price of AZBJ shares?
As of July 01, 2025, the stock is trading at USD 34.84 with a total of 20,375 shares traded.
Over the past week, the price has changed by +1.12%, over one month by +1.95%, over three months by +4.90% and over the past year by +7.95%.
Is AllianzIM U.S. Large Cap a good stock to buy?
Yes. Based on ValueRay's Analyses, AllianzIM U.S. Large Cap (NYSE ARCA:AZBJ) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 67.68 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AZBJ is around 33.32 USD . This means that AZBJ is currently overvalued and has a potential downside of -4.36%.
Is AZBJ a buy, sell or hold?
AllianzIM U.S. Large Cap has no consensus analysts rating.
What are the forecasts for AZBJ share price target?
According to our own proprietary Forecast Model, AZBJ AllianzIM U.S. Large Cap will be worth about 36.9 in July 2026. The stock is currently trading at 34.84. This means that the stock has a potential upside of +5.97%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 36.9 6%